ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer

Abstract ABIN-1, also called TNIP1, is an ubiquitin-binding protein that serves an important role in suppressing RIPK1-independent apoptosis, necroptosis, and NF-κB activation. However, the involvement of ABIN-1 in the regulation of RIPK1-dependent apoptosis (RDA) is unknown. In this study, we found...

Full description

Bibliographic Details
Main Authors: Jiali Cai, Die Hu, Judy Sakya, Tao Sun, Daoyong Wang, Lin Wang, Xiaohua Mao, Zhenyi Su
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-021-03427-y
id doaj-98a85561cbee4548b47f62e977420574
record_format Article
spelling doaj-98a85561cbee4548b47f62e9774205742021-02-07T12:05:12ZengNature Publishing GroupCell Death and Disease2041-48892021-02-0112211510.1038/s41419-021-03427-yABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancerJiali Cai0Die Hu1Judy Sakya2Tao Sun3Daoyong Wang4Lin Wang5Xiaohua Mao6Zhenyi Su7Department of Biochemistry and Molecular Biology, School of Medicine, Southeast UniversitySchool of Life Science and Technology, Southeast UniversitySchool of Medicine, Texas Tech University Health Sciences CenterDepartment of Biochemistry and Molecular Biology, School of Medicine, Southeast UniversityDepartment of Biochemistry and Molecular Biology, School of Medicine, Southeast UniversitySchool of Medicine, Southeast UniversityDepartment of Biochemistry and Molecular Biology, School of Medicine, Southeast UniversityDepartment of Biochemistry and Molecular Biology, School of Medicine, Southeast UniversityAbstract ABIN-1, also called TNIP1, is an ubiquitin-binding protein that serves an important role in suppressing RIPK1-independent apoptosis, necroptosis, and NF-κB activation. However, the involvement of ABIN-1 in the regulation of RIPK1-dependent apoptosis (RDA) is unknown. In this study, we found that poly(I:C) + TAK1 inhibitor 5Z-7-oxozeaenol (P5) concurrently induces RDA and necroptosis in Abin-1 −/−, but not in Abin-1 +/+ mouse embryonic fibroblasts (MEFs). Upon P5 stimulation, cells initially die by necroptosis and subsequently by RDA. Furthermore, we explored the therapeutic effect of ABIN-1 deficiency in necroptosis-based cancer therapy in colorectal cancer (CRC). We found that poly(I:C) + 5Z-7-oxozeaenol + IDN-6556 (P5I) yields a robust pro-necroptosis response, and ABIN-1 deficiency additionally enhances this P5I-induced necroptosis. Moreover, phase I/II cIAP inhibitor birinapant with clinical caspase inhibitor IDN-6556 (BI) alone and 5-fluorouracil with IDN-6556 (FI) alone are sufficient to induce necroptotic cell death in CRC cells by promoting auto-secretion of tumor necrosis factor (TNF); ABIN-1 deficiency amplifies the BI- or FI-induced necroptosis. Two independent xenograft experiments using HT-29 or COLO205 cells show that both BI and P5I remarkably inhibit tumor growth via necroptosis activation. For poly(I:C)-induced cell death, the sensitizing effect of ABIN-1 deficiency on cell death may be attributed to increased expression of TLR3. In TNF-induced necroptosis, ABIN-1 deficiency increases TNF-induced RIPK1 polyubiquitination by reducing the recruitment of ubiquitin-editing enzyme A20 to the TNFR1 signaling complex and induces more TNF secretion in CRC cells upon pro-necroptosis stimulation. With this combined data, ABIN-1 deficiency promotes greater sensitization of CRC cells to necroptosis.https://doi.org/10.1038/s41419-021-03427-y
collection DOAJ
language English
format Article
sources DOAJ
author Jiali Cai
Die Hu
Judy Sakya
Tao Sun
Daoyong Wang
Lin Wang
Xiaohua Mao
Zhenyi Su
spellingShingle Jiali Cai
Die Hu
Judy Sakya
Tao Sun
Daoyong Wang
Lin Wang
Xiaohua Mao
Zhenyi Su
ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
Cell Death and Disease
author_facet Jiali Cai
Die Hu
Judy Sakya
Tao Sun
Daoyong Wang
Lin Wang
Xiaohua Mao
Zhenyi Su
author_sort Jiali Cai
title ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_short ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_full ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_fullStr ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_full_unstemmed ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
title_sort abin-1 is a key regulator in ripk1-dependent apoptosis (rda) and necroptosis, and abin-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
publisher Nature Publishing Group
series Cell Death and Disease
issn 2041-4889
publishDate 2021-02-01
description Abstract ABIN-1, also called TNIP1, is an ubiquitin-binding protein that serves an important role in suppressing RIPK1-independent apoptosis, necroptosis, and NF-κB activation. However, the involvement of ABIN-1 in the regulation of RIPK1-dependent apoptosis (RDA) is unknown. In this study, we found that poly(I:C) + TAK1 inhibitor 5Z-7-oxozeaenol (P5) concurrently induces RDA and necroptosis in Abin-1 −/−, but not in Abin-1 +/+ mouse embryonic fibroblasts (MEFs). Upon P5 stimulation, cells initially die by necroptosis and subsequently by RDA. Furthermore, we explored the therapeutic effect of ABIN-1 deficiency in necroptosis-based cancer therapy in colorectal cancer (CRC). We found that poly(I:C) + 5Z-7-oxozeaenol + IDN-6556 (P5I) yields a robust pro-necroptosis response, and ABIN-1 deficiency additionally enhances this P5I-induced necroptosis. Moreover, phase I/II cIAP inhibitor birinapant with clinical caspase inhibitor IDN-6556 (BI) alone and 5-fluorouracil with IDN-6556 (FI) alone are sufficient to induce necroptotic cell death in CRC cells by promoting auto-secretion of tumor necrosis factor (TNF); ABIN-1 deficiency amplifies the BI- or FI-induced necroptosis. Two independent xenograft experiments using HT-29 or COLO205 cells show that both BI and P5I remarkably inhibit tumor growth via necroptosis activation. For poly(I:C)-induced cell death, the sensitizing effect of ABIN-1 deficiency on cell death may be attributed to increased expression of TLR3. In TNF-induced necroptosis, ABIN-1 deficiency increases TNF-induced RIPK1 polyubiquitination by reducing the recruitment of ubiquitin-editing enzyme A20 to the TNFR1 signaling complex and induces more TNF secretion in CRC cells upon pro-necroptosis stimulation. With this combined data, ABIN-1 deficiency promotes greater sensitization of CRC cells to necroptosis.
url https://doi.org/10.1038/s41419-021-03427-y
work_keys_str_mv AT jialicai abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT diehu abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT judysakya abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT taosun abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT daoyongwang abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT linwang abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT xiaohuamao abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
AT zhenyisu abin1isakeyregulatorinripk1dependentapoptosisrdaandnecroptosisandabin1deficiencypotentiatesnecroptosisbasedcancertherapyincolorectalcancer
_version_ 1724281709653917696